References
- Coburn R F. The airway smooth muscle cell. Fed Proc 1977; 36: 2692–2697
- Creese B R, Denborough M A. Sources of calcium for contraction of guinea-pig isolated tracheal smooth muscle. Clin Exp Pharm Physiol 1981; 8: 175–182
- Middleton E, Jr. Antiasthmatic drug therapy and calcium ions: Review of pathogenesis and role of calcium. J Pharm Sci 1980; 69: 243–251
- Foreman J C, Hallet M B, Mongar J L. The relationship between histamine secretion and 45calcium uptake by mast cells. J Physiol 1977; 271: 193–214
- Weiss E B. Calcium and excitation-contraction coupling in vascular smooth muscles. Can J Physiol Pharmacol 1982; 60: 483–488
- Williams D O, Barnes P J, Vickers H P, Rudolf M. Effect of nifedipine on bronchomotor tone and histamine reactivity in asthma. Br Med J 1981; 283: 348
- Barnes P J, Wilson N M, Brown M J. A calcium antagonist, nifedipine, modifies exercised-induced asthma. Thorax 1981; 36: 726–730
- Corris P A, Nariman S, Gibson G J. Nifedipine in the prevention of asthma induced by exercise and histamine. Am Rev Respir Dis 1983; 228: 991–992
- Malik S, O'Reilly J, Sudlow M F. Effects of sublingual nifedipine on inhaled histamine and methacholine-induced bronchoconstriction in atopic subjects. Thorax 1982; 37: 230, (abstract)
- Patel K R, Al-Shamma M. Effect of nifedipine on histamine reactivity in asthma. Br Med J 1982; 284: 1916–1918
- Malo P E, Wasserman M A, Griffin R L. Effects of intravenous and aerosol nifedipine on prostaglandin F2 and histamine-induced bronchoconstriction in anesthetized dogs. J Pharmacol Exp Ther 1982; 221: 410–415
- Fanta C H, Venugopalan C S, Lacouture P G, Drazen J M. Inhibition of bronchoconstriction in the guinea pig by a calcium channel blocker, nifedipine. Am Rev Respir Dis 1982; 125: 61–66
- Patel K R. The effect of verapamil on histamine and methacholine induced bronchoconstriction. Clin Allergy 1981; 11: 441–447
- McLntyre E, Fitzgibbon B, Otto H, Minson R, Alpers J, Ruffin R. Inhaled verapamil in histamineinduced bronchoconstriction. J Allergy Clin Immunol 1983; 71: 375–381
- Russi E W, Marchette B, Yerger L, Abraham W M, Ahmed T. Modification of allergic bronchoconstriction by a calcium antagonist: Mode of action. Am Rev Respir Dis 1983; 127: 675–679
- Gonzalez J M, Moricke R C, Bloom K, Akers S, Raizner A E, Stevens P M. Inhibition of airway reactivity by nifedipine in patients with coronary artery disease. Am Rev Respir Dis 1983; 127: 155–157
- Brugman T M, Darnell M L, Hirshmn C A. Nifedipine aerosol attenuates airway constriction in dogs with hyperreactive airways. Am Rev Respir Dis 1983; 127: 14–17
- Cerrina J, Denjean A, Alexandre G, Lockhart A, Duroux P. Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine. Am Rev Respir Dis 1981; 123: 156–160
- Patel K R. The effect of calcium antagonist, nifedipine, in exercise-induced asthma. Clin Allergy 1981; 11: 429–432
- Patel K R. Calcium antagonists in exercise-induced asthma. Br Med J 1981; 282: 932–933
- Solway J, Fanta C H, Collins L, McFadden E R, Jr. Inhibition of bronchoconstriction during isocapnic hyperventilation of cold air by calcium channel blockers. Am Rev Respir Dis 1983; 127(4,Part 2))92, (abstract)
- Henderson A F, Heaton R W, Costello J F. Effect of nifedipine on bronchoconstriction induced by inhalation of cold air. Thorax 1983; 38: 12–515
- Fanta C H. Role of calcium in airway smooth muscle contraction and mast cell secretion. J Asthma 1984; 21(6))387–405
- Cockroft D W, Killian D N, Mellon J JA, Hargreave F E. Protective effective of drugs on histamineinduced asthma. Thorax 1977; 32: 429–437
- Salome C M, Schoeffel R E, Woolcock A F. Effect of aerosol and oral fenoterol on histamine and methacholine challenge in asthmatic subjects. Thorax 1981; 36: 580–584
- Deal E C, Jr, Wasserman S I, Soter N A, Ingram R H, Jr, McFadden E R, Jr. Evaluation of the role played by the mediators of immediate hypersensitivity in exercise-induced asthma. J Clin Invest 1980; 65: 659–665
- Townley R G. Role of calcium channel blocking agents in the treatment of allergic asthma. J Asthma 1984; 21(6))427–442